Lung Cancer in Patients with Severe Idiopathic Pulmonary Fibrosis: Critical Aspects.

about

Stereotactic body radiation therapy (SBRT) in the management of non-small-cell lung cancer: Clinical impact and patient perspectives.

P2860

Q55282076-F27A092C-256C-4F30-8FBC-D86F680B2FB4

P2860

Lung Cancer in Patients with Severe Idiopathic Pulmonary Fibrosis: Critical Aspects.

Item

http://www.wikidata.org/entity/Q41487554

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Lung Cancer in Patients with Severe Idiopathic Pulmonary Fibrosis: Critical Aspects.

@en

type

Item

label

Lung Cancer in Patients with Severe Idiopathic Pulmonary Fibrosis: Critical Aspects.

@en

prefLabel

Lung Cancer in Patients with Severe Idiopathic Pulmonary Fibrosis: Critical Aspects.

@en

P1476

Lung Cancer in Patients with Severe Idiopathic Pulmonary Fibrosis: Critical Aspects

@en

P2093

Alessandra Bindi

http://www.w3.org/2001/XMLSchema#string

Elisabetta Rosi

http://www.w3.org/2001/XMLSchema#string

Katia Ferrari

http://www.w3.org/2001/XMLSchema#string

Luca Voltolini

http://www.w3.org/2001/XMLSchema#string

Moroni Chiara

http://www.w3.org/2001/XMLSchema#string

Viola Bonti

http://www.w3.org/2001/XMLSchema#string

P2860

Nintedanib in NSCLC: evidence to date and place in therapy

New perspectives on management of idiopathic pulmonary fibrosis

Profile of nintedanib in the treatment of solid tumors: the evidence to date

Clinical trials of investigational agents for IPF: a review of a Cochrane report

Idiopathic pulmonary fibrosis will increase the risk of lung cancer

Common pathways in idiopathic pulmonary fibrosis and cancer

New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)

Idiopathic pulmonary fibrosis: prevailing and evolving hypotheses about its pathogenesis and implications for therapy

A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis

An official American Thoracic Society/European Respiratory Society statement: Update of the international multidisciplinary classification of the idiopathic interstitial pneumonias

P304

773-777

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.21873/INVIVO.11130

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Maurizio Bartolucci

Elena Bargagli

P577

2017-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28652456

http://www.w3.org/2001/XMLSchema#string

P921

pulmonary fibrosis

P932

5566939

http://www.w3.org/2001/XMLSchema#string

Lung Cancer in Patients with Severe Idiopathic Pulmonary Fibrosis: Critical Aspects.

about

P2860

P2860

Lung Cancer in Patients with Severe Idiopathic Pulmonary Fibrosis: Critical Aspects.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921

P932